Omega Fund Management’s Sana Biotechnology SANA Stock Holding History

Omega Fund Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.43M	Hold	843,750	–	–	1.49%	8
2025 Q4	$3.43M	Hold	843,750	–	–	1.2%	9
2025 Q3	$3M	Hold	843,750	–	–	1.35%	9
2025 Q2	$2.3M	Hold	843,750	–	–	1.49%	9
2025 Q1	$1.42M	Hold	843,750	–	–	0.84%	12
2024 Q4	$1.38M	Hold	843,750	–	–	0.89%	10
2024 Q3	$3.51M	Hold	843,750	–	–	2.19%	8
2024 Q2	$4.61M	Hold	843,750	–	–	3.41%	7
2024 Q1	$8.44M	Hold	843,750	–	–	5.44%	5
2023 Q4	$3.44M	Hold	843,750	–	–	2.79%	9
2023 Q3	$3.27M	Hold	843,750	–	–	3%	7
2023 Q2	$5.03M	Hold	843,750	–	–	2.82%	8
2023 Q1	$2.76M	Hold	843,750	–	–	1.8%	10
2022 Q4	$3.33M	Hold	843,750	–	–	1.12%	11
2022 Q3	$5.06M	Hold	843,750	–	–	1.85%	12
2022 Q2	$5.42M	Hold	843,750	–	–	1.73%	12
2022 Q1	$6.97M	Hold	843,750	–	–	1.43%	13
2021 Q4	$13.1M	Hold	843,750	–	–	1.85%	10
2021 Q3	$19M	Hold	843,750	–	–	2.13%	10
2021 Q2	$16.6M	Hold	843,750	–	–	1.88%	11
2021 Q1	$28.2M	Buy	+843,750	New	+$27.5M	2.67%	10

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Omega Fund Management's SANA Position: Q1 2026 in Review

Omega Fund Management held its Sana Biotechnology (SANA) position steady in Q1 2026 at 843,750 shares worth $2.43M. The position accounts for 1.49% of the portfolio, ranked #8.

Omega Fund Management first reported a position in SANA in Q1 2021 and has held it in 21 quarters since. The position peaked at $28.2M in Q1 2021. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Omega Fund Management held 843,750 shares of Sana Biotechnology worth $2.43M as of Q1 2026.
Omega Fund Management left its Sana Biotechnology share count unchanged in Q1 2026.
Sana Biotechnology made up 1.49% of Omega Fund Management's portfolio in Q1 2026, its #8 holding.
Omega Fund Management first reported a position in Sana Biotechnology in Q1 2021 and has held it in 21 quarters since.
Omega Fund Management's Sana Biotechnology position peaked at $28.2M in Q1 2021.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Omega Fund Management's 13F filing for Q1 2026, filed 15 May 2026.